Top Markets
#1 Black Phoenix Black Phoenix +21,534.66%
#2 Nesa Nesa +729.63%
#3 Kinesis Silver Kinesis Silver +54.95%
#4 BNB Attestation Service BNB Attestation Service +26.00%
#5 QuantixAI QuantixAI +24.05%
#6 EXOD EXOD +22.78%
#7 Pons Pons +20.03%
#8 Biconomy Biconomy +19.45%
#9 Derive Derive +18.54%
#10 Cash Cat Cash Cat +16.88%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Inari Medical, Inc. Inari Medical, Inc.

Inari Medical, Inc.

NARI
Rangering i aksjer #3846
Inari Medical, Inc. is a medical technology firm focused on creating,... Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
Aksjekurs
$79.97
Sist synkronisert: 2025-02-19
Markedsverdi
$4.57B
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Inari Medical, Inc. (NARI)

Kategori

Healthcare
P/E-forhold for Inari Medical, Inc. (NARI)
P/E-forhold per August 2026 TTM: -2.78K
Ifølge Inari Medical, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) -2.78K. Ved slutten av 2022 hadde selskapet en P/E på -114.75.
P/E-forholdshistorikk for Inari Medical, Inc. fra 2018 til 2026
P/E-forhold ved slutten av hvert år
År P/E-forhold Endre
2026 (TTM) -2.78K 23.26%
2023 -2.25K 1,863.22%
2022 -114.75 -124.83%
2021 462.06 127.86%
2020 202.79 -118.88%
2019 -1.07K 470.60%
2018 -188.21 0.00%
P/E-forhold for lignende selskaper eller konkurrenter
Selskap P/E-forhold Forskjell i P/E-forhold Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -101.29%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -101.26%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -100.77%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -100.75%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE
Hvordan lese en P/E-ratio?

Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.

Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.

Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.